Vincent Leroy

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Marc Bourlière, Jean-Pierre Bronowicki, Victor de Lédinghen et al. · The Lancet Infectious Diseases · 2015 · 281 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid

Vincent Leroy, Frédérique Monier, Serge P. Bottari et al. · The American Journal of Gastroenterology · 2004 · 256 citations

Medicine, Infectious Diseases, Pathology +17

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience

Audrey Coilly, Bruno Roche, Jérôme Dumortier et al. · Journal of Hepatology · 2013 · 196 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results

Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell et al. · Journal of Hepatology · 2017 · 125 citations

Medicine, Internal Medicine, Surgery +13